CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 174.45
+4.45 (2.62%)
At close: Jan 8, 2026
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 81.96 billion as of January 8, 2026. Its market cap has decreased by -39.14% in one year.
Market Cap
81.96B
Enterprise Value
99.37B
Revenue
23.73B
Ranking
n/a
PE Ratio
18.06
Stock Price
174.45
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 81.96B, an increase of 26,170.21%. That is a compound annual growth rate of 19.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 81.96B | -1.53% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.03B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |
| Neuren Pharmaceuticals | 2.31B |